Back to top
more

Universal Health Services (UHS)

(Delayed Data from NYSE)

$205.26 USD

205.26
632,500

+0.95 (0.46%)

Updated Nov 1, 2024 04:00 PM ET

After-Market: $205.49 +0.23 (0.11%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value B Growth F Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 11% (28 out of 250)

Industry: Medical - Hospital

Better trading starts here.

Zacks News

INSPIRA (IINN) CART Gets FDA Listing, to Enhance Healthcare

Inspira (IINN) announces FDA listing of its INSPIRA CART, designed for use with the ART100 system, enhancing healthcare delivery during cardiopulmonary bypass.

Why Is Universal Health Services (UHS) Up 11.9% Since Last Earnings Report?

Universal Health Services (UHS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Stryker's (SYK) Inks Deal to Aid Its Pain Management Portfolio

Stryker (SYK) is set to acquire Vertos Medical to expand its interventional pain management portfolio.

Inogen (INGN) Rises 127% Year to Date: What's Driving the Stock?

Expanding product portfolio and high prospects for POC raise optimism for the Inogen (INGN) stock.

Glaukos (GKOS) Gains 63.5% YTD: What's Driving the Stock?

Investors are optimistic about Glaukos' (GKOS) strength in its flagship iStent.

Cencora (COR) Gains 16.6% YTD: What's Driving the Stock?

Cencora (COR) gaining traction from the robust U.S. Healthcare Solutions segment raises optimism about the stock.

PROCEPT BioRobotics' (PRCT) HYDROS System Gets FDA Clearance

PROCEPT BioRobotics (PRCT) announces the FDA 510(k) clearance of its HYDROS Robotic System for providing better BPH treatment.

Cardinal Health (CAH) to Open New Distribution Center in Ohio

Cardinal Health's (CAH) new center is set to integrate cutting-edge technology and automation, enhancing efficiency, storage capacity and quality of service.

CollPlant (CLGN), Stratasys Initiate Study for Breast Implants

CollPlant (CLGN) and Stratasys announce the initiation of a pre-clinical study to focus on the ability of implants to grow natural breast tissue and completely degrade over time.

Avinger (AVGR) Launches Pantheris LV to Boost PAD Treatment

Avinger (AVGR) fully launches Pantheris LV, the first image-guided atherectomy system for large vessels, thus enhancing peripheral artery disease treatment with advanced technology.

Reasons to Hold Cencora (COR) Stock in Your Portfolio for Now

Cencora (COR) continues to gain traction from the robust U.S. Healthcare Solutions segment. However, stiff competition is a woe.

Here's Why You Should Retain Nevro (NVRO) Stock for Now

Strength in Nevro's (NVRO) Senza Platform raises optimism about the stock.

Brookdale (BKD) Down 7% Since Q2 Earnings Miss on Lower Interest

Brookdale (BKD) expects adjusted EBITDA for the third quarter in the range of $90-$95 million.

Why You Should Add HCA Healthcare (HCA) to Your Portfolio Now

HCA Healthcare (HCA) remains well-poised for growth on growing emergency room visits, buyouts and solid cash flows.

Boston Scientific (BSX), Silk Road Merger Delayed for Review

Boston Scientific (BSX) withdraws its premerger notification and report form to give the U.S. FTC more time to review the proposed acquisition of Silk Road Medical.

Enovis (ENOV) Introduces STAR Ankle With e+ Polyethylene

Enovis (ENOV) brings the first mobile-bearing ankle system with e+ Polyethylene, which offers enhanced durability, stability and longevity for improved patient outcomes.

Zacks.com featured highlights Universal Health, General Motors, EnerSys and Itron

Universal Health, General Motors, EnerSys and Itron have been highlighted in this Screen of The Week article.

Zacks Industry Outlook Highlights HCA Healthcare, Universal Health Services, Tenet Healthcare, Acadia Healthcare and Community Health Systems

HCA Healthcare, Universal Health Services, Tenet Healthcare, Acadia Healthcare and Community Health Systems have been highlighted in this Industry Outlook article.

Kaibalya Pravo Dey headshot

5 Hospital Stocks Poised to Benefit From Strong Industry Growth

The Zacks Medical-Hospital industry will gain from increasing admissions and cybersecurity and technological advancements. Companies like HCA, UHS, THC, ACHC and CYH are poised to gain from these trends.

Microbot Medical (MBOT) Gets Quality Certification for its System

Microbot Medical (MBOT) secures ISO 13485:2016 certification for its LIBERTY Endovascular Robotic System, a milestone that streamlines European and FDA regulatory compliance for future commercialization.

Harshit Gupta headshot

McKesson (MCK) Stock Gains 18% YTD: What's Driving the Rally?

McKesson's (MCK) shares rally on the back of solid fundamentals. Increasing volumes of prescription and specialty drugs boost the top line.

Should Value Investors Buy Universal Health Services (UHS) Stock?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Vasundhara Sawalka headshot

4 Stocks Trading Near 52-Week High With More Upside Potential

Investors target stocks that have lately been on a bull run. Stocks like PPC, THC, DVA and UHS are seeing price strength and have a high chance of carrying the momentum forward.

Sumit Singh headshot

4 Low P/CF Stocks to Buy Now as Market Confidence Soars

Value investing is essentially about selecting stocks that are usually cheap but fundamentally sound. UHS, GM, ENS & ITRI boast low P/CF ratios.

Masimo (MASI) Gets New Suitors for Its Consumer Business Sale

Masimo (MASI) receives unsolicited requests from multiple entities for acquiring its consumer business. The company already received a non-binding term sheet confirmation from a third party in May.